Roche’s live audio webcast and conference call from ESMO IO 2017


Agenda:
IMpower150: Phase 3 results of carboplatin + paclitaxel +/- Avastin, with or without Tecentriq in 1L non-squamous metastatic NSCLC	Alan Sandler, M.D., Global Development Team Leader Tecentriq Lung
Tecentriq program overview: Focusing on novel combination approaches	Cathi Ahearn, Global Product Strategy Tecentriq

Please register to access the replay* *Privacy notice

First Name *

Last name *

Corporate Email *

Company Name *

Country/Region *

confirm you are a human *

Investors

Downloads

PDF

PDF